Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event
A 67-year-old man developed metabolic alkalosis during treatment with bumetanide for diuretic therapy1 .
The man, who had hypertension and diabetes, presented with hypoxia due to COVID-19 pneumonia. He was hospitalised and intubated for hypercapnic respiratory failure. Because of worsening dyspnoea, he was started on bumetanide drip [dosage and route not stated] on day 34 of admission; however, due to diuresis with bumetanide, bicarbonate concentration (HCO3-), partial pressure of carbon dioxide (paCO2) and arterial pH increased. On day 46 bicarbonate concentration reached 70 mEq/L, causing severe metabolic alkalosis.
The man's bumetanide treatment was stopped. His condition improved. Subsequently, he developed acute kidney injury, oliguria and azotaemia with a rise in serum creatinine. He had worsening anion gap metabolic acidosis secondary to uraemia. His COVID-19 worsened leading to acute tubular necrosis and worsening septic shock. Owing to his multi-organ failure, he was transferred to comfort care on day 51. He died after few hours due to multi-organ failure.
Footnotes
Country of occurrence, reporter country and primary source country not stated. Unable to contact author.
Reference
- Chen Etchison E, et al. SEVERE RESPIRATORY ACIDOSIS AND METABOLIC ALKALOSIS IN A PATIENT WITH COVID-19 ARDS. Chest 160 (Suppl.): A2154, No. 4, 1 Oct 2021. Available from: URL: 10.1016/j.chest.2021.07.1903 [abstract] [DOI]
